Increased physical activity following the diagnosis of cancer has been demonstrated to significantly improve outcome, but the underlying mechanisms are not well understood. Because chronic stress contributes to aggressive tumor growth, we hypothesized that stress-reducing behavior, such as voluntary exercise, will counteract stress-mediated tumor growth. To test this hypothesis, we utilized an orthotopic mouse model of ovarian carcinoma. Thirty-six mice were divided into four groups: no treatment; free access to an exercise wheel; 2 h of daily immobilization stress; 2 h daily immobilization stress plus voluntary exercise. Mice were monitored daily for overall health and wheel use and were sacrificed and autopsied when the first mice became moribund. Exercise had no significant eect on the growth rate of tumors in unstressed animals. However, stressed mice with no access to exercise demonstrated accelerated SKOV3ip1 tumor growth as compared to the unstressed controls (0.45 g vs. 0.2 g; p = 0.03). Stressed mice with voluntary exercise developed significantly smaller tumors than stressed mice housed without wheels (0.15 g vs. 0.45 g, p = 0.02), which were similar in size to those observed in unstressed animals. Furthermore, we demonstrated similar therapeutic eects when mice were treated with a daily dose of 10 mg/kg of the antidepressant, fluoxetine. Exercise clearly reverses stress-induced tumor growth. The beneficial eects of exercise on tumor growth can be mimicked with antidepressants, suggesting that exercise and antidepressants utilize common signaling pathways to prevent cancer recurrence. Immunosuppressed populations are at particular risk for health changes associated with the stress of chronic illness. To test the possibility that relaxation and guided imagery (RGI) mitigates the biobehavioral sequelae associated with HIV infection, we examined changes in psychophysiological indicators of stress in HIV+ adults who regularly practice RGI. Participants from a Midwestern AIDS Clinical Trial Unit were randomly assigned to either undergo a 12-week RGI protocol (n = 14) or serve as wait list controls (n = 11). RGI consisted of intensive instruction in general relaxation plus individualized active coping imagery exercises with weekly follow-up. Outcomes were assessed at baseline (week 2) plus weeks 6, 10, and 14. Whereas there was no significant change in viral load from baseline to week 14 among the RGI participants, among the wait list control participants, viral load increased significantly over the 12-week wait. That a statistically significant increase in CD4 + cells was also evident in the RGI group during this period suggests there was a biologic benefit of the intervention. Behaviorally, compared to wait-list controls, RGI participants exhibited significant improvements on the MOS-HIV Role Function and Health Transition subscales and overall health behavior (p = 0.05). There was also some suggestion of treatment related reduction in psychological distress evidenced by improvement trends on the POMS total and six POMS subscales. Anecdotally, RGI was found useful for nine most frequently reported symptoms including pain and fatigue. These findings support the possibility that RGI interventions can improve biobehavioral HIV sequelae. Variability in cortisol concentrations has been observed among the aging. Inter-individual variability and age-related cortisol changes are difficult to distinguish from changes linked to stressful conditions. We evaluated the relationship among subjective sleep, indices of stress, and 24-h salivary cortisol concentrations (AUC) in two groups of ''stressed" individuals: bereaved (BR) (N = 27, 71.6 ± 6.4 years, 76% female) and spousal caregivers (CG) of patients with dementia (N = 42, 73.5 ± 7.1 years; 74% female), and in a group of elders (HC) without significant sleep complaints or medical comorbidity (N = 49, Brain, Behavior, and Immunity 22 
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